Trials / Recruiting
RecruitingNCT04191395
Evolution and Treatments of Chronic Inflammatory Systemic Diseases
Evolution and Treatments of Chronic Inflammatory Systemic Diseases: Implementation of a Hospital Cohort in the Gastroenterology, Dermatology and Rheumatology Departments of the University Hospital of Besançon
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points. The pathologies concerned are inflammatory bowel diseases (IBD - Crohn's disease \[MC\] and ulcerative colitis \[RCH\]), chronic inflammatory skin diseases (psoriasis or Verneuil's disease) and chronic inflammatory rheumatic diseases (rheumatoid arthritis \[RA\] and spondyloarthritis \[SpA\] including psoriatic arthritis \[PsA\]). Presenting one of these diseases is associated with a higher risk of having a second inflammatory pathology, whether the latter is ophthalmological, dermatological, rheumatological or gastroenterological. An association of extra-articular manifestations is observed in 10 to 30% of patients with SpA, and an association of extra-intestinal manifestations is observed in approximately 30% of patients with IBD. No common database for chronic systemic inflammatory diseases currently exists in France.
Conditions
- Inflammatory Bowel Diseases
- Ulcerative Colitis
- Crohn Disease
- Arthritis, Rheumatoid
- Spondyloarthritis
- Psoriatic Arthritis
- Psoriasis
- Verneuil's Disease
Timeline
- Start date
- 2019-12-11
- Primary completion
- 2029-12-01
- Completion
- 2029-12-01
- First posted
- 2019-12-09
- Last updated
- 2024-11-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04191395. Inclusion in this directory is not an endorsement.